Clinical trials
Completed Small Cell Lung Carcinoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 3 |
| M.D. Anderson Cancer Center | 2 |
| Massachusetts General Hospital | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Butler Hospital | 1 |
| Cancer Trials Ireland | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| City of Hope Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 34 |
| Carcinoma, Non-Small-Cell Lung | 25 |
| Lung Neoplasms | 21 |
| Esophageal Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Colonic Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.